Medication info
Tagatin Tablets (Cimetidine)

Tagatin Tablets (Cimetidine)

Prescription medicationTabletOral
Ingredient · strength
Cimetidine›200mg / 1 tablet
Manufacturer / importer
Withus Pharmaceutical Co., Ltd.
Appearance
This medicine is a light green, round tablet.
Packaging
500 tablets/bottle
Approval status
Active

MFDS item code 198902026 · Notified 1989.12.12 · Insurance code 660701730

Summary

Main use
Treats ulcers and reflux esophagitis, etc.; treats Zollinger-Ellison syndrome; and improves gastric lesions
Who takes it
Adults · Children
Adult dose
Adults: Administer 400 mg of cimetidine per dose orally 2 times daily (in the morning and at bedtime), or administer 800 mg once daily (at bedtime). Alternatively, administer 300 mg per dose orally 4 times daily (after meals and at bedtime). The dose may be increased up to 400 mg per dose 4 times daily (after meals and at bedtime) (total 1.6 g). However, for improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis, administer 200 mg per dose 2 times daily or 400 mg once daily. An antacid may be administered as needed to relieve pain. The dose may be increased depending on the patient; in such cases, increase the number of doses rather than the dose per administration. Do not exceed 2.4 g daily. Patients with renal impairment: Administer 300 mg of this medicine per dose 2 times daily, every 12 hours. If necessary according to the patient's symptoms, the number of doses may be increased to 3 times daily, every 8 hours, or more often, but use caution. Since the medicine may accumulate in the body in patients with severe renal impairment, reduce the number of doses to the minimum according to the patient's response. Hemodialysis lowers the cimetidine level in the blood. After hemodialysis is completed, administer the medicine again according to the schedule. Dosage may be adjusted as appropriate according to age and symptoms.
Child dose
Children: Administer 20 ~ 40 mg per kg of body weight daily orally in divided doses.

Ingredients

Manufacturer
Withus Pharmaceutical Co., Ltd.

Efficacy & effects

Treats ulcers and reflux esophagitis, etc.; treats Zollinger-Ellison syndrome; and improves gastric lesions

  • Gastric ulcer
  • duodenal ulcer
  • gastroesophageal reflux disease
  • recurrent ulcer
  • anastomotic ulcer
  • Zollinger-Ellison syndrome
  • gastric mucosal lesions
  • erosion
  • bleeding
  • redness
  • swelling
  • acute gastritis
View approved original text

This medication is used to treat various gastrointestinal disorders such as ulcers in the stomach and duodenum, gastroesophageal reflux disease, recurrent ulcers, postoperative anastomotic ulcers, and Zollinger-Ellison syndrome. It is also effective in improving lesions such as erosion, bleeding, redness, and swelling of the gastric mucosa that occur during the acute exacerbation of acute and chronic gastritis. In summary, this drug is used to treat gastrointestinal ulcers and inflammatory lesions.

How to take

Adult dose

Adults: Administer 400 mg of cimetidine per dose orally 2 times daily (in the morning and at bedtime), or administer 800 mg once daily (at bedtime). Alternatively, administer 300 mg per dose orally 4 times daily (after meals and at bedtime). The dose may be increased up to 400 mg per dose 4 times daily (after meals and at bedtime) (total 1.6 g). However, for improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis, administer 200 mg per dose 2 times daily or 400 mg once daily. An antacid may be administered as needed to relieve pain. The dose may be increased depending on the patient; in such cases, increase the number of doses rather than the dose per administration. Do not exceed 2.4 g daily. Patients with renal impairment: Administer 300 mg of this medicine per dose 2 times daily, every 12 hours. If necessary according to the patient's symptoms, the number of doses may be increased to 3 times daily, every 8 hours, or more often, but use caution. Since the medicine may accumulate in the body in patients with severe renal impairment, reduce the number of doses to the minimum according to the patient's response. Hemodialysis lowers the cimetidine level in the blood. After hemodialysis is completed, administer the medicine again according to the schedule. Dosage may be adjusted as appropriate according to age and symptoms.

Child dose

Children: Administer 20 ~ 40 mg per kg of body weight daily orally in divided doses.

Precautions

When this medication is provided in glass ampoule form, care must be taken when opening the container as glass fragments may mix in. Particular caution should be exercised when used by children or the elderly. Patients allergic to or who have experienced hypersensitivity reactions to any component of this drug should not be administered this medication. Also, patients taking certain cardiac arrhythmia medications may be at risk when using this drug. Patients with lactose intolerance or certain genetic metabolic disorders should not take this medication. Patients with impaired kidney or liver function, the elderly, children under 19 years, and patients undergoing hemodialysis should use this medication with caution as dosage adjustments or interval modifications may be necessary. This medication may hide symptoms of gastric cancer, so it should only be used after confirming the malignancy, and patients infected with Helicobacter pylori should also receive eradication treatment. This medication should be used with caution in patients allergic to Yellow No. 4 (Tartrazine). During use, there may be occurrences of blood cell count reduction, liver function abnormalities, kidney function issues, allergic reactions, hormonal imbalances, gastrointestinal symptoms, neurological anomalies, heart rhythm disturbances, or serious skin reactions. If any abnormal symptoms occur, consult a physician immediately. This drug may interact with other medications; therefore, especially when taken alongside anticoagulants, anticonvulsants, cardiac medications, antibiotics, and antidepressants, dosage adjustments or discontinuation may be required as directed by a physician. For women who are pregnant or may become pregnant, the administration of this drug should be decided carefully, and nursing women should discontinue breastfeeding if taking this medication. The safety of this drug in children has not been sufficiently confirmed, so it should only be used when absolutely necessary. Elderly patients may experience increased drug concentrations due to decreased kidney function, so dosages should be reduced or administration intervals extended. In cases of overdose, serious side effects such as respiratory depression can occur, so appropriate medical treatment should be obtained immediately. When administered intravenously, rapid injection may cause arrhythmias or decreased blood pressure, so injections should be performed slowly. This medication should be stored out of reach of children, and transferring it to another container should be avoided as it may cause accidents and loss of quality.

Side effects

  • Leukopenia
  • agranulocytosis
  • aplastic anemia
  • thrombocytopenia
  • pancytopenia
  • aplastic anemia
  • immune hemolytic anemia
  • jaundice
  • hepatitis
  • elevated AST
Show 47 more
  • elevated ALT
  • hepatic fibrosis
  • interstitial convulsions
  • acute renal failure
  • interstitial nephritis
  • urinary retention
  • elevated BUN
  • shock
  • anaphylactoid reaction
  • hypersensitive vasculitis
  • rash
  • gynecomastia
  • hypersecretion of lactation
  • increased leukorrhea
  • erectile dysfunction
  • abdominal distension
  • constipation
  • diarrhea
  • headache
  • dizziness
  • convulsions
  • limb numbness
  • rigidity
  • drowsiness
  • hypochondriac symptoms
  • weakness
  • altered consciousness
  • delirium
  • bradycardia
  • tachycardia
  • palpitations
  • atrioventricular block
  • skin and mucous membrane syndrome
  • toxic epidermal necrolysis
  • epidermal necrosis
  • erythema multiforme
  • exfoliative dermatitis
  • generalized exfoliative erythema
  • fatigue
  • fever
  • systemic warmth
  • dysuria
  • myalgia
  • arthralgia
  • pancreatitis
  • hair loss
  • polymyositis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container that blocks light, and it is recommended to keep it at a temperature between 1 and 30 degrees Celsius at room temperature. By storing it this way, the effectiveness of the medication can be maintained for a longer period.

Appearance and packaging

Appearance

This medicine is a light green, round tablet.

Package unit

500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.